Australian Regenerative Medicine Institute
The Australian Regenerative Medicine Institute (ARMI) is a $153 million medical research centre that opened in April 2009.[1] It is based at the Clayton campus of Monash University, in the Monash Science Technology Research and Innovation Precinct, along with the Australian Stem Cell Centre.[2] Its foundation director is Professor Nadia Rosenthal.[3][4] Rosenthal has previously served at the European Molecular Biology Laboratory and Harvard Medical School. While at Harvard, she was part of the team that discovered the insulin gene.[5]
ARMI is one of the world's largest regenerative medicine and stem cell research hubs.[6] Its research aims to restore and regenerate damaged tissue and organs by injecting or implanting cells to allow the human body to heal and recover.[7] Research focuses on developing effective treatments for a range of currently incurable diseases, such as cancer, arthritis and other musculoskeletal conditions, diabetes and cardiovascular diseases, as well as neurotrauma. In addition, ARMI is also looking at technologies to treat ageing itself via regeneration.
Facilities at the Institute include FishCore, the largest zebrafish facility of its kind in the Southern Hemisphere.[8]
External links
References
- ^ Australian Regenerative Medicine Institute - ARMI
- ^ Growing success, Monash Magazine, Issue 20, Spring/Summer 2007
- ^ International Scientific Leader to Head Victoria, Australia's Regenerative Medicine Institute | Market Wire | Find Articles at BNET
- ^ Australian Life Scientist - Rosenthal to head regenerative institute
- ^ Monash academic to head Victoria's Regenerative Medicine Institute - (Monash Memo, 9 May 2007)
- ^ Media Release: VICTORIA TO HOST KEY SEMINARS AT BIO2006
- ^ http://www.business.vic.gov.au/BUSVIC/STANDARD//pc=PC_61419.html
- ^ http://www.armi.org.au/Facilities/FishCore.aspx